Item 2. Properties
ITEM
2.
Properties
and Facilities
We
lease a 14,507 square foot manufacturing facility in Irvine, California under a lease that expires on September 30, 2027. Our facility
is designed expressly for the manufacture of biologic vascular grafts and is equipped for research and development, prototype fabrication,
cGMP manufacturing and shipping for Class III medical devices, including biologic cardiovascular devices. We believe that our facilities
are sufficient for the near future as there is present capacity to manufacture up to approximately 24,000 venous valves per year to meet
potential market demands.
ITEM
3.
Legal
Proceedings
None.
ITEM
4.
Mine
and Safety Disclosure
Not
applicable.
26
PART
II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.